205 related articles for article (PubMed ID: 16103065)
1. OLIG2 (BHLHB1), a bHLH transcription factor, contributes to leukemogenesis in concert with LMO1.
Lin YW; Deveney R; Barbara M; Iscove NN; Nimer SD; Slape C; Aplan PD
Cancer Res; 2005 Aug; 65(16):7151-8. PubMed ID: 16103065
[TBL] [Abstract][Full Text] [Related]
2. SCL, LMO1 and Notch1 reprogram thymocytes into self-renewing cells.
Gerby B; Tremblay CS; Tremblay M; Rojas-Sutterlin S; Herblot S; Hébert J; Sauvageau G; Lemieux S; Lécuyer E; Veiga DF; Hoang T
PLoS Genet; 2014 Dec; 10(12):e1004768. PubMed ID: 25522233
[TBL] [Abstract][Full Text] [Related]
3. Notch1 mutations are important for leukemic transformation in murine models of precursor-T leukemia/lymphoma.
Lin YW; Nichols RA; Letterio JJ; Aplan PD
Blood; 2006 Mar; 107(6):2540-3. PubMed ID: 16282337
[TBL] [Abstract][Full Text] [Related]
4. Gene expression profiling of precursor T-cell lymphoblastic leukemia/lymphoma identifies oncogenic pathways that are potential therapeutic targets.
Lin YW; Aplan PD
Leukemia; 2007 Jun; 21(6):1276-84. PubMed ID: 17429429
[TBL] [Abstract][Full Text] [Related]
5. An scl gene product lacking the transactivation domain induces bony abnormalities and cooperates with LMO1 to generate T-cell malignancies in transgenic mice.
Aplan PD; Jones CA; Chervinsky DS; Zhao X; Ellsworth M; Wu C; McGuire EA; Gross KW
EMBO J; 1997 May; 16(9):2408-19. PubMed ID: 9171354
[TBL] [Abstract][Full Text] [Related]
6. Modeling T-cell acute lymphoblastic leukemia induced by the SCL and LMO1 oncogenes.
Tremblay M; Tremblay CS; Herblot S; Aplan PD; Hébert J; Perreault C; Hoang T
Genes Dev; 2010 Jun; 24(11):1093-105. PubMed ID: 20516195
[TBL] [Abstract][Full Text] [Related]
7. scid Thymocytes with TCRbeta gene rearrangements are targets for the oncogenic effect of SCL and LMO1 transgenes.
Chervinsky DS; Lam DH; Melman MP; Gross KW; Aplan PD
Cancer Res; 2001 Sep; 61(17):6382-7. PubMed ID: 11522630
[TBL] [Abstract][Full Text] [Related]
8. SCL and LMO1 alter thymocyte differentiation: inhibition of E2A-HEB function and pre-T alpha chain expression.
Herblot S; Steff AM; Hugo P; Aplan PD; Hoang T
Nat Immunol; 2000 Aug; 1(2):138-44. PubMed ID: 11248806
[TBL] [Abstract][Full Text] [Related]
9. Combined expression of pTalpha and Notch3 in T cell leukemia identifies the requirement of preTCR for leukemogenesis.
Bellavia D; Campese AF; Checquolo S; Balestri A; Biondi A; Cazzaniga G; Lendahl U; Fehling HJ; Hayday AC; Frati L; von Boehmer H; Gulino A; Screpanti I
Proc Natl Acad Sci U S A; 2002 Mar; 99(6):3788-93. PubMed ID: 11891328
[TBL] [Abstract][Full Text] [Related]
10. Notch1 contributes to mouse T-cell leukemia by directly inducing the expression of c-myc.
Sharma VM; Calvo JA; Draheim KM; Cunningham LA; Hermance N; Beverly L; Krishnamoorthy V; Bhasin M; Capobianco AJ; Kelliher MA
Mol Cell Biol; 2006 Nov; 26(21):8022-31. PubMed ID: 16954387
[TBL] [Abstract][Full Text] [Related]
11. Activating Notch1 mutations in mouse models of T-ALL.
O'Neil J; Calvo J; McKenna K; Krishnamoorthy V; Aster JC; Bassing CH; Alt FW; Kelliher M; Look AT
Blood; 2006 Jan; 107(2):781-5. PubMed ID: 16166587
[TBL] [Abstract][Full Text] [Related]
12. Disordered T-cell development and T-cell malignancies in SCL LMO1 double-transgenic mice: parallels with E2A-deficient mice.
Chervinsky DS; Zhao XF; Lam DH; Ellsworth M; Gross KW; Aplan PD
Mol Cell Biol; 1999 Jul; 19(7):5025-35. PubMed ID: 10373552
[TBL] [Abstract][Full Text] [Related]
13. Notch1 inhibition targets the leukemia-initiating cells in a Tal1/Lmo2 mouse model of T-ALL.
Tatarek J; Cullion K; Ashworth T; Gerstein R; Aster JC; Kelliher MA
Blood; 2011 Aug; 118(6):1579-90. PubMed ID: 21670468
[TBL] [Abstract][Full Text] [Related]
14. Development and characterization of T cell leukemia cell lines established from SCL/LMO1 double transgenic mice.
Chervinsky DS; Lam DH; Zhao XF; Melman MP; Aplan PD
Leukemia; 2001 Jan; 15(1):141-7. PubMed ID: 11243382
[TBL] [Abstract][Full Text] [Related]
15. bHLH-zip transcription factor Spz1 mediates mitogen-activated protein kinase cell proliferation, transformation, and tumorigenesis.
Hsu SH; Hsieh-Li HM; Huang HY; Huang PH; Li H
Cancer Res; 2005 May; 65(10):4041-50. PubMed ID: 15899793
[TBL] [Abstract][Full Text] [Related]
16. Identification of the LMO4 gene encoding an interaction partner of the LIM-binding protein LDB1/NLI1: a candidate for displacement by LMO proteins in T cell acute leukaemia.
Grutz G; Forster A; Rabbitts TH
Oncogene; 1998 Nov; 17(21):2799-803. PubMed ID: 9840944
[TBL] [Abstract][Full Text] [Related]
17. NOTCH1-induced T-cell leukemia in transgenic zebrafish.
Chen J; Jette C; Kanki JP; Aster JC; Look AT; Griffin JD
Leukemia; 2007 Mar; 21(3):462-71. PubMed ID: 17252014
[TBL] [Abstract][Full Text] [Related]
18. p16INK4A tumor suppressor gene expression and CD3epsilon deficiency but not pre-TCR deficiency inhibit TAL1-linked T-lineage leukemogenesis.
Fasseu M; Aplan PD; Chopin M; Boissel N; Bories JC; Soulier J; von Boehmer H; Sigaux F; Regnault A
Blood; 2007 Oct; 110(7):2610-9. PubMed ID: 17507663
[TBL] [Abstract][Full Text] [Related]
19. Cooperation of Gata3, c-Myc and Notch in malignant transformation of double positive thymocytes.
van Hamburg JP; de Bruijn MJ; Dingjan GM; Beverloo HB; Diepstraten H; Ling KW; Hendriks RW
Mol Immunol; 2008 Jun; 45(11):3085-95. PubMed ID: 18471881
[TBL] [Abstract][Full Text] [Related]
20. LMO3 interacts with neuronal transcription factor, HEN2, and acts as an oncogene in neuroblastoma.
Aoyama M; Ozaki T; Inuzuka H; Tomotsune D; Hirato J; Okamoto Y; Tokita H; Ohira M; Nakagawara A
Cancer Res; 2005 Jun; 65(11):4587-97. PubMed ID: 15930276
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
